As both GH and IGF-1 display promising effects with respect to cognition and neuroprotection, it is possible that these hormones can be used as viable treatments for cognitive impairments in the CNS.Accumulating evidence suggest that opioids such as methadone may induce cognitive disorders. The gene discussed is GH1; the disease is Cognitive impairment.